Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
Deutsches Zentrum für Neurodegenerative Erkrankungen | Gottingen, Niedersachsen | Germany | about 2 months ago
tools and pipelines, as well as methods for quality control, differential expression, and integrative analyses. Proven expertise in non-coding RNA (ncRNA) biology and epigenetics within the neurosciences
-
Applicants are invited for the above vacancy, based in Epigenetics of Haematopoiesis laboratory at The University of Manchester, tenable from 1 December 2025 until 30 November 2026. Chronic
-
Infrastructure? No Offer Description • Conducting classes for students in the fields of genetics, epigenetics, molecular biology, and laboratory diagnostics, including courses taught in English. • Maintaining and
-
determined pending application date and program needs. Group or Departmental Website: http://flentje.stanford.edu (link is external) How to Submit Application Materials: Submit your application via this link
-
, including gene expression, epigenetic, endocrine, and behavioral datasets. Responsibilities include supporting data processing workflows, assisting with molecular assays, and collaborating closely with other
-
epigenetic regulators, both in physiological and pathological conditions. In the context of a project funded by the French Research Agency (ANR), you will characterise a potential new class of transcriptional
-
which viruses hijack chromatin. Due to the major advancement in sequencing technologies and the expansion of the field of epigenetics, exploiting viruses to investigate chromatin biology has enormous
-
McGill University | Winnipeg Sargent Park Daniel McIntyre Inkster SE, Manitoba | Canada | 3 months ago
: Department of Pharmacology & Therapeutics Course Title and Course Number: Epigenetic Drugs and Targets - PHAR 565 Estimated Number of Positions: 1 Total Hours of Work per Term: 45 hours per position Position
-
lethal interactions as new therapeutic strategies for tumours defective in DNA repair or epigenetic processes. Our team closely collaborates with the Drug Development Department and the sarcoma committee
-
, epigenetics, metabolism, tumor heterogeneity, tumor microenvironment, and the effects of therapy on normal brain tissue. Candidates focused on pediatric or adult brain tumor research, and with a strong interest